NCT03638427View on ClinicalTrials.gov

Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood

CompletedOBSERVATIONAL

Enrollment

159

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

October 11, 2022

Study Completion Date

November 30, 2022

Conditions

HPV - Anogenital Human Papilloma Virus Infection

Interventions

DIAGNOSTIC_TEST

Menstrual Blood Analysis (Menstrual Blood Analysis)

We will be testing women's menstrual blood to investigate the feasibility and efficacy of assessing HR-HPV DNA and HPV E6/E7 mRNA via self-collected menstrual blood from a menstrual pad.

Trial Locations (1)

94304

Stanford Gynecology Clinic, Palo Alto

All Listed Sponsors

lead

Stanford University

OTHER

NCT03638427 - Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood | Biotech Hunter | Biotech Hunter